Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histotripsy (HistoSonics®) for Liver Tumours: a Phase II Safety and Efficacy Study

NCT06579833 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06579833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06579833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histotripsy (HistoSonics®) for Liver Tumours: a Phase II Safety and Efficacy Study
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 29, 2024
Completion date
September 1, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver tumour